A needle-free semaglutide option Semaglutide GLP-1 drops offer a convenient, needle-free alternative for those looking to manage weight and support metabolic health
In the United Kingdom, approximately 5.2 million adults (7.7%, aged 18-74) and 2.5 million children (18%, aged 0-17) are affected by moderate or severe atopic dermatitis, also known as atopic eczema
Most patients see noticeable improvements after one treatment, but for the best results, a series of sessions is usually recommended
Retatrutide is an investigational triple GLP-1/GIP/glucagon receptor agonist not approved by the MHRA or EMA
If youve just been prescribed GLP-1 medications, commonly known as Ozempic, Wegovy, Mounjaro, Zepbound, Semaglutide or Tirzepatide, you might be feeling equal parts hope and hesitation
Both options can be prescribed by licensed clinicians